Clinical Trial Update: Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating thalidomide plus carboplatin for pediatric brain stem glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Stem Glioma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Thalomid (thalidomide)

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Brain Stem Neoplasms, Primary, Neoplasms, Brain Stem | Phase 2 | Status: COMPLETED